Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New chest tube method may cut complications after heart surgery

NCT ID NCT07505966

Knowledge-focused Sponsor: Kasr El Aini Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at two methods of draining blood and fluid from the chest after heart surgery. It compared a newer active clearance method that keeps tubes open with standard passive drainage. Researchers reviewed records of 250 adult patients from three heart surgery centers to see which method led to fewer complications like retained blood, reoperations, and shorter hospital stays. No new treatments were given; the goal is to improve future care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

250 people

The number who actually took part.

Started

Jan 2022

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients who underwent cardiac surgery with mediastinal chest tube placement at participating tertiary cardiac surgery centers. Data will be collected retrospectively from medical records; no direct patient contact occurs.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years) undergoing cardiac surgery via median sternotomy, including CABG, valve surgery, or combined procedures. Placement of mediastinal chest tubes postoperatively Exclusion Criteria: * Redo sternotomy Surgery for acute aortic dissection Heart transplantation Mechanical circulatory support implantation Incomplete or missing essential medical records Intraoperative death

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chest tube are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chest tube Open heart surgery Retained blood syndrome

Contacts and locations

Locations

  • Assiut University Faculty of Medicine

    Asyut, Egypt

  • Beni Suef University Faculty of Medicine

    Banī Suwayf, Egypt

  • Cairo University Hospital

    Cairo, 02, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.